ACTIVE_NOT_RECRUITING

Epidemiology of Young Lung Cancer - Survey

Talk to us

Conditions

NSCLC

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a 100% virtual (remote), case-case study to explore potential environmental, lifestyle and genetic factors that may be associated with driver mutations of young lung cancer in the U.S.

Official Title

This is a 100% Virtual (Remote) Study (Survey, and Voluntary Blood Donation) to Explore Potential Environmental, Lifestyle and Genetic Factors That May be Associated With Driver Mutations of Young Lung Cancer in the USA.

Quick Facts

Study Start:2021-02-01
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT04640259

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male or female aged 18 years and over; or the age of majority for their residential state at the time of enrollment
  2. 2. Documentation of primary NSCLC, any stage
  3. 3. Less than 50 years of age at the time of NSCLC diagnosis
  4. 4. Documentation of testing by a CLIA certified lab for genomic drivers of lung cancer
  5. 5. Willingness to undergo all study procedure
  6. 6. Provision of written informed consent
  1. 1. Male or female aged less than 18 years; or less than the age of majority for their residential state
  2. 2. Greater than or equal to 50 years of age at the time of NSCLC diagnosis
  3. 3. No documentation of mutation testing
  4. 4. Unwilling to undergo all study procedures
  5. 5. Unable or unwilling to provide consent

Contacts and Locations

Principal Investigator

Jorge Nieva, MD
PRINCIPAL_INVESTIGATOR
University of Southern California
Barbara Gitlitz, MD
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

USC Keck School of Medicine
Los Angeles, California, 90033
United States
Addario Lung Cancer Medical Institute
San Carlos, California, 94070
United States

Collaborators and Investigators

Sponsor: Addario Lung Cancer Medical Institute

  • Jorge Nieva, MD, PRINCIPAL_INVESTIGATOR, University of Southern California
  • Barbara Gitlitz, MD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-02-01
Study Completion Date2026-03

Study Record Updates

Study Start Date2021-02-01
Study Completion Date2026-03

Terms related to this study

Additional Relevant MeSH Terms

  • NSCLC